Literature DB >> 1347787

Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1.

D R Lucey1, C W Hendrix, C Andrzejewski, G P Melcher, C A Butzin, R Henry, F H Wians, R N Boswell.   

Abstract

European patients with human immunodeficiency virus type 1 (HIV-1) infection have been reported to have lower titers of anti-p24 antibody than Central African HIV seropositive patients. Recently, black HIV positive patients in the United States were reported to be more likely to have detectable anti-p24 antibodies, less p24 antigenemia, and higher combined serum immunoglobulins than white HIV positive patients. We measured individual total serum immunoglobulins in 853 HIV positive patients (94% male; 58% white and 42% black) on their initial medical evaluation and compared them with CD4+ T-cell counts. Blacks had notably higher IgG levels (p = 0.001) across the entire spectrum of CD4+ T-cell counts. Serum IgM levels were slightly higher in blacks. IgA levels were not significantly different between the races, although the trend (p = 0.006) was toward higher levels in whites. We also measured these three serum immunoglobulins in 60 HIV seronegative, healthy blood donors (30 black and 30 white). In this control group, blacks had statistically higher IgG and IgA levels than whites. A review of the literature prior to the HIV/acquired immune deficiency syndrome epidemic also supports the view that racial differences in IgG levels are not specific for HIV infection. We speculate that racial differences in humoral immunity, independent of geography or strain of HIV, may account for differences in anti-HIV antibody levels and HIV antigenemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347787

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  10 in total

1.  Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.

Authors:  Oliver Laeyendecker; Ron Brookmeyer; Amy E Oliver; Caroline E Mullis; Kevin P Eaton; Amy C Mueller; Lisa P Jacobson; Joseph B Margolick; Joelle Brown; Charles R Rinaldo; Thomas C Quinn; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-01       Impact factor: 2.205

Review 2.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  Predictors of survival in human immunodeficiency virus type 1-seropositive intravenous drug users.

Authors:  J B Page; S Lai; M A Fletcher; R Patarca; P C Smith; H C Lai; N G Klimas
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

4.  Interaction of menstrual cycle phase and sexual activity predicts mucosal and systemic humoral immunity in healthy women.

Authors:  Tierney K Lorenz; Gregory E Demas; Julia R Heiman
Journal:  Physiol Behav       Date:  2015-09-21

Review 5.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Transcriptome Analysis Reveals Intrinsic Proinflammatory Signaling in Healthy African American Skin.

Authors:  Anna Klopot; Gleb Baida; Alexander Kel; Lam C Tsoi; Bethany E Perez White; Irina Budunova
Journal:  J Invest Dermatol       Date:  2021-10-29       Impact factor: 7.590

7.  Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS.

Authors:  Simon Swingler; Jin Zhou; Catherine Swingler; Ann Dauphin; Thomas Greenough; Paul Jolicoeur; Mario Stevenson
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

Review 8.  Fc receptors and the diversity of antibody responses to HIV infection and vaccination.

Authors:  Li-Yun Lin; Raphael Carapito; Bin Su; Christiane Moog
Journal:  Genes Immun       Date:  2022-06-10       Impact factor: 4.248

9.  HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.

Authors:  L Morris; J M Binley; B A Clas; S Bonhoeffer; T P Astill; R Kost; A Hurley; Y Cao; M Markowitz; D D Ho; J P Moore
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

10.  Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia.

Authors:  Admire Hlupeni; Antonio Nakouzi; Tao Wang; Kathryn F Boyd; Tariro A Makadzange; Chiratidzo E Ndhlovu; Liise-Anne Pirofski
Journal:  Open Forum Infect Dis       Date:  2018-12-11       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.